Zealand Pharma A/S (ZEAL) 2015年CSR报告「NASDAQ」.pdf

1、 Zealand Pharma A/S Smedeland 36 DK-2600 Glostrup Denmark Statutory Report on:Corporate Social Responsibility(CSR)2015 Statutory report on Corporate Social Responsibility for the financial year 2015 cf.Section 99a and 99b of the Danish Financial Statements Act1.This report is a supplement to the Man

2、agements review in the Annual Report 2015 covering the period 1 January-31 December 2015.1In Danish Lovpligtig redegrelse for samfundsansvar,jf.rsregnskabsloven 99a og 99b Zealand Pharma A/S 1/9 Corporate Social Responsibility(CSR)Report for 2015 1.Zealand and CSR Our Corporate Social Responsibility

3、(CSR)work is an integrated part of Zealands business and our efforts in the area are based on our core values.We believe that Zealand has an obligation to be socially responsible in order to benefit not only Zealands main stakeholders,being mainly shareholders,patients and employees,but also to soci

4、ety.It remains a key focus for us across our business to have an open,engaging and respectful communication with all our stakeholders.Our CSR efforts are based on the most admissible elements of some of the most widely implemented CSR initiatives in the world,notably the Global Reporting Initiative(

5、GRI)and the United Nations Global Compact.Zealand has found in these two systems complementary frameworks for both guiding and reporting its CSR activities along several principles in the areas of labor,the environment,human rights and anti-corruption.In addition to these,we have supplemented a prov

6、isional category for animal rights owing to the unique exigencies of our industry.Zealand is a maturing biotech company with established scientific expertise and a leading-edge position in turning peptides into medicines.Our therapeutic focus lies in specialty disease areas where peptide-based medic